Great Point Partners’s Albireo Pharma Inc ALBO Stock Holding History

Great Point Partners’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-267,283	Closed	-$5.78M	–	57
2022 Q4	$5.78M	Buy	+267,283	New	+$5.65M	1.13%	33
2015 Q4	–	Sell	-110,566	Closed	-$1.46M	–	29
2015 Q3	$1.46M	Sell	110,566 -23,151	-17%	-$583K	0.58%	28
2015 Q2	$4.13M	Buy	+133,717	New	+$4.49M	1.61%	22
2013 Q4	–	Sell	-44,483	Closed	-$4.2M	–	37
2013 Q3	$4.2M	Buy	+44,483	New	+$5.79M	2.92%	12

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Great Point Partners's ALBO Position: Q1 2023 in Review

Great Point Partners sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 267,283 shares — an estimated $5.78M sold.

Great Point Partners first reported a position in ALBO in Q3 2013 and held it in 4 quarters. The position peaked at $5.78M in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Great Point Partners reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Great Point Partners sold 267,283 Albireo Pharma Inc shares in Q1 2023, an estimated $5.78M.
Great Point Partners first reported a position in Albireo Pharma Inc in Q3 2013 and held it in 4 quarters.
Great Point Partners's Albireo Pharma Inc position peaked at $5.78M in Q4 2022.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Great Point Partners's 13F filing for Q1 2023, filed 15 May 2023.